Biomarkers Consortium To Investigate Lung Cancer, Non-Hodgkins Lymphoma
This article was originally published in The Pink Sheet Daily
Executive Summary
Public-private biomedical research partnership will also investigate biomarkers in major depressive disorder, diabetes and pre-diabetes.
You may also be interested in...
FDA Centers Will Change To Meet Requirements Of Personalized Medicine - Von Eschenbach
Acting commissioner says agency must streamline regulatory decision making for combination diagnostic and therapeutic products.
FDA Centers Will Change To Meet Requirements Of Personalized Medicine - Von Eschenbach
Acting commissioner says agency must streamline regulatory decision making for combination diagnostic and therapeutic products.
Bay Area Biotech Roundtable: What Does It Take To Excel In The Global Marketplace? (Part 2 of 3)
Avigen, Genomic Health, Nuvelo, Poniard and Rigel execs sit down with "The Pink Sheet" DAILY to discuss Asia, pharmacogenomics, and FDA's position on biomarkers.